MedPath

ASAN FOUNDATION

ASAN FOUNDATION logo
🇰🇷South Korea
Ownership
Private
Established
1989-06-23
Employees
501
Market Cap
-
Website
https://ails.amc.seoul.kr

A Multicenter Prospective Phase II Study of Modified FOLFIRINOX for 1st Line Treatment for Advanced Urachus Cancer

Phase 2
Recruiting
Conditions
Urachal Cancer
Interventions
First Posted Date
2020-11-02
Last Posted Date
2020-11-02
Lead Sponsor
Asan Medical Center
Target Recruit Count
35
Registration Number
NCT04611724
Locations
🇰🇷

Asan Medical Center, Seoul, Korea, Republic of

Safety of Human Embryonic Stem Cell (hESC)-Derived Mesenchymal Stem Cells in Interstitial Cystitis

Phase 1
Conditions
Stem Cell Transplant
Mesenchymal Stem Cell
Interstitial Cystitis
Interventions
First Posted Date
2020-10-30
Last Posted Date
2020-10-30
Lead Sponsor
Asan Medical Center
Target Recruit Count
3
Registration Number
NCT04610359
Locations
🇰🇷

Department of Urology, Asan Medical Center, Seoul, Korea, Republic of

Music and Surgery Associated With Relationship and Satisfaction

Not Applicable
Conditions
Breast Cancer
Interventions
Procedure: Music therapy
First Posted Date
2020-09-18
Last Posted Date
2020-10-06
Lead Sponsor
Asan Medical Center
Target Recruit Count
304
Registration Number
NCT04555057
Locations
🇰🇷

Asan Medical Center, Seoul, Korea, Republic of

Randomized, Open-label Trial of Inhibitory Effect of Evogliptin on Progression of CAVD

Phase 4
Not yet recruiting
Conditions
CAVD
Interventions
First Posted Date
2020-08-20
Last Posted Date
2020-08-20
Lead Sponsor
Asan Medical Center
Target Recruit Count
218
Registration Number
NCT04521452
Locations
🇰🇷

Asan Medical Center, Seoul, Korea, Republic of

PD-1 Inhibitor INCMGA00012 as Consolidation Therapy After Definitive Concurrent Chemoradiotherapy

Phase 2
Active, not recruiting
Conditions
Esophageal Cancer
Interventions
First Posted Date
2020-07-31
Last Posted Date
2025-04-20
Lead Sponsor
Asan Medical Center
Target Recruit Count
110
Registration Number
NCT04494009
Locations
🇰🇷

Asan Medical Center, Seoul, Korea, Republic of

Diagnostic Validity of [18F]FSPG PET for the Assessment of Acute Rejection After Heart or Liver Transplantation

Phase 2
Completed
Conditions
Liver Transplantation
Graft Rejection
Heart Transplantation
Interventions
Drug: [18F]FSPG
First Posted Date
2020-07-27
Last Posted Date
2023-07-20
Lead Sponsor
Asan Medical Center
Target Recruit Count
7
Registration Number
NCT04488094
Locations
🇰🇷

Asan Medical Center, Seoul, Korea, Republic of

Change of Gut Microbiome and Symptom After H.Pylori Eradication Therapy in Patients With Functional Dyspepsia

First Posted Date
2020-06-26
Last Posted Date
2020-06-26
Lead Sponsor
Asan Medical Center
Target Recruit Count
60
Registration Number
NCT04449185

FFR and Inducible Myocardial Ischemia During Adenosine Stress Testing

Not Applicable
Conditions
Coronary Artery Stenosis
Interventions
Diagnostic Test: Fractional flow reserve with adenosine stress testing
First Posted Date
2020-05-26
Last Posted Date
2021-07-21
Lead Sponsor
Asan Medical Center
Target Recruit Count
150
Registration Number
NCT04401657
Locations
🇰🇷

Asan Medical Center, Seoul, Korea, Republic of

Sarcopenia and Outcomes of Neuroplasty in Lumbar Spinal Stenosis

Active, not recruiting
Conditions
Lumbar Spinal Stenosis
Neurogenic Claudication
Sarcopenia
Interventions
Procedure: Neuroplasty with Racz catheter
First Posted Date
2020-05-05
Last Posted Date
2022-12-27
Lead Sponsor
Asan Medical Center
Target Recruit Count
79
Registration Number
NCT04374669
Locations
🇰🇷

Asan medical center, Seoul, Korea, Republic of

Pilot Study on Withdrawal of Spironolactone Among Heart Failure With Improved Ejection Fraction

Not Applicable
Completed
Conditions
Heart Failure
Interventions
First Posted Date
2020-04-29
Last Posted Date
2023-10-05
Lead Sponsor
Asan Medical Center
Target Recruit Count
62
Registration Number
NCT04367051
Locations
🇰🇷

Asan Medical Center, Seoul, Songpa-gu, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath